Could we be more present for our loved ones?
Let’s explore memory loss together.
Memory loss can happen to anyone, including ourselves or the people we love. But it may be possible to get ahead of the symptoms, and participating in clinical research may help us get there. Let’s discover what’s possible together.
Let’s explore memory loss together.
Memory loss can happen to anyone, including ourselves or the people we love. But it may be possible to get ahead of the symptoms, and participating in clinical research may help us get there. Let’s discover what’s possible together.
About the
Memory Loss Study
The causes of memory loss and Alzheimer’s disease are not yet fully understood. What we do know is that changes in the brain begin 10 to 20 years before thinking or memory problems appear. That’s why some research studies for memory loss focus on people showing symptoms, while others focus on people who may be at risk. Research on this condition is so important because there is still a need to find effective treatments.
Lilly is currently conducting the following clinical research study for memory loss:
The TRAILRUNNER-ALZ 1 Study is evaluating how safe an investigational drug is and how effective it is at removing amyloid plaques associated with memory and thinking issues for people with early symptoms of Alzheimer’s disease.
You or a loved one may be able to take part in the TRAILRUNNER-ALZ 1 Study if you:
- Are 60 to 85 years of age
- Have memory loss that has gotten worse over time
- Have a trusted study partner* who knows you well and who can help answer questions about your health and help with study visits and procedures
- Meet additional study needs
The TRAILRUNNER-ALZ 2 Study is evaluating how safe an investigational drug is and how effective it is at slowing memory and thinking issues for people with early symptoms of Alzheimer’s disease.
You or a loved one may be able to take part in the TRAILRUNNER-ALZ 2 Study if you:
- Are 60 to 85 years of age
- Have memory loss that has gotten worse over time
- Have a trusted study partner* who knows you well and who can help answer questions about your health and help with study visits and procedures
- Meet additional study needs
The TRAILBLAZER-ALZ 3 Study is evaluating how safe an investigational drug is and how effective it is at slowing or preventing memory and thinking issues for people who have normal memory and thinking, but who are at risk for Alzheimer’s disease.
You or a loved one may be able to take part in the TRAILBLAZER-ALZ 3 Study if you:
- Are [55/65] to 80 years of age
- Have normal memory, thinking, mood, and behavior patterns
- Have a trusted study partner* who knows you well and can answer questions from the study team about you during video calls
- Meet additional study needs
*The study partner must be able to speak about the participant’s day-to-day routines and any changes with the research staff throughout the study.